Martín et al., 2023 - Google Patents
Faecalibacterium: a bacterial genus with promising human health applicationsMartín et al., 2023
View PDF- Document ID
- 12730228085897794203
- Author
- Martín R
- Rios-Covian D
- Huillet E
- Auger S
- Khazaal S
- Bermúdez-Humarán L
- Sokol H
- Chatel J
- Langella P
- Publication year
- Publication venue
- FEMS Microbiology Reviews
External Links
Snippet
In humans, many diseases are associated with alterations in gut microbiota, namely increases or decreases in the abundance of specific bacterial groups. One example is the genus Faecalibacterium. Numerous studies have underscored that low levels of …
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Martín et al. | Faecalibacterium: a bacterial genus with promising human health applications | |
| Crost et al. | Ruminococcus gnavus: friend or foe for human health | |
| Lee et al. | The gut microbiome: what the oncologist ought to know | |
| Wang et al. | Core gut bacteria analysis of healthy mice | |
| Lin et al. | Investiture of next generation probiotics on amelioration of diseases–Strains do matter | |
| Sanz et al. | Understanding the role of gut microbes and probiotics in obesity: how far are we? | |
| Gerritsen et al. | Intestinal microbiota in human health and disease: the impact of probiotics | |
| Guarner | Enteric flora in health and disease | |
| Rupa et al. | Recent advances in the role of probiotics in human inflammation and gut health | |
| Ballini et al. | About functional foods: The probiotics and prebiotics state of art | |
| Salazar et al. | Safety and intestinal microbiota modulation by the exopolysaccharide-producing strains Bifidobacterium animalis IPLA R1 and Bifidobacterium longum IPLA E44 orally administered to Wistar rats | |
| Saulnier et al. | Microbiology of the human intestinal tract and approaches for its dietary modulation | |
| Wang et al. | Maternal consumption of a fermented diet protects offspring against intestinal inflammation by regulating the gut microbiota | |
| US20160271189A1 (en) | Methods and compositions relating to microbial treatment and diagnosis of skin disorders | |
| US20150104423A1 (en) | Use of blood group status iii | |
| CN108064132A (en) | The method and composition related with the antimicrobial treatments of illness and diagnosis | |
| EP2598155A2 (en) | Use of blood group status iii | |
| Elmén et al. | Dietary emulsifier sodium stearoyl lactylate alters gut microbiota in vitro and inhibits bacterial butyrate producers | |
| Zhu et al. | Effects of exopolysaccharide from Lactobacillus rhamnosus on human gut microbiota in in vitro fermentation model | |
| Salgaço et al. | Probiotic infant cereal improves children’s gut microbiota: Insights using the Simulator of Human Intestinal Microbial Ecosystem (SHIME®) | |
| Salvadori et al. | Microbiota, renal disease and renal transplantation | |
| Moroeanu et al. | Probiotic strains influence on infant microbiota in the in vitro colonic fermentation model GIS1 | |
| Fujiwara | Crosstalk between intestinal microbiota derived metabolites and tissues in allogeneic hematopoietic cell transplantation | |
| Alagiakrishnan et al. | Approach to the diagnosis and management of dysbiosis | |
| Wang et al. | The emerging role of the gut microbiota and its application in inflammatory bowel disease |